PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'RAND Corporation, Santa Monica, CA, United States of America. Electronic address: jcantor@rand.org.\', \'RAND Corporation, Boston, MA, United States of America.\', \'RAND Corporation, Boston, MA, United States of America; Department of Health Management & Policy, University of Michigan, United States of America.\', \'Castlight Health, San Francisco, CA, United States of America.\', \'Castlight Health, San Francisco, CA, United States of America; Center for Primary Care and Outcomes Research, Stanford, CA, United States of America.\', \'RAND Corporation, Pittsburgh, PA, United States of America.\', \'RAND Corporation, Santa Monica, CA, United States of America.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0740-5472(21)00110-010.1016/j.jsat.2021.108384
?:doi
?:hasPublicationType
?:journal
  • Journal of substance abuse treatment
is ?:pmid of
?:pmid
?:pmid
  • 34080552
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.311
?:rankingScore_hIndex
  • 91
is ?:relation_isRelatedTo_publication of
?:title
  • Use of buprenorphine for those with employer-sponsored insurance during the initial phase of the COVID-19 pandemic.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34080552>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34080552>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all